21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
ANTI-AXL ANTIBODIES
#11102BINDING MOLECULES BINDING PD-L1 AND LAG-3
#11103METHODS OF ANTI-TUMOR THERAPY
#11104Anti-CD100 antibodies and methods for using the same
#11105METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
#11106METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES
#11107Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
#11108PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
#11109PHARMACEUTICAL COMPOUNDS AND THERAPEUTIC METHODS
#11110Benzazole compounds and methods for making and using the compounds
#11111Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
#11112PROLYL HYDROXYLASE INHIBITORS
#11113NOVEL TERNARY MOLECULAR COMPLEX OF TAMIBAROTENE FOR CANCER STEM CELLS TREATMENT
#11114Micro- and nano-fluidic chip, method of fabricating the same, and applications thereof
#11115PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES
#11116THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
#11117Combination treatment for atopic dermatitis
#11118MRNA BASED ENZYME REPLACEMENT THERAPY COMBINED WITH A PHARMACOLOGICAL CHAPERONE FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS
#11119PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE
#11120TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS
#11121Polypeptides for treatment of cancer
#11122AMPK/CASPASE-6 AXIS CONTROLS LIVER DAMAGE IN NONALCOHOLIC STEATOHEPATITIS
#11123Stamina-improving composition and stamina-improving natural tea comprising same
#11124PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY HERPESVIRIDAE
#11125Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by Paramyxoviridae
#11126MEDICINAL VAGINAL LACTOBACILLUS COCKTAIL
#11127THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY
#11128Genetically Engineered Cells and Uses Thereof
#11129MEDICAL AND NUTRITIONAL COMPOSITIONS AND METHODS OF USE
#11130Polymer nanoparticle, polymer composition, method of making a polymer nanoparticle, method for treatment of bacterial biofilms, and method for detection of bacterial biofilms
#11131METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
#11132PHARMACEUTICAL COMPOSITION INJECTABLE INTO URINARY TRACT ORGAN CAVITY FOR PREVENTION OR TREATMENT OF UROTHELIAL CANCER
#11133COMBINATION THERAPY FOR CANCER TREATMENT
#11134Parasite therapy
#11135Betulin-containing birch bark extracts and their formulation
#11136COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE
#11137Uses of DPP IV inhibitors
#11138FORMULATIONS OF A COMPOUND MODULATING KINASES
#11139PHARMACEUTICAL COMPOSITION FOR TREATING AORTIC ANEURYSM
#11140COMBINATION TREATMENT OF OCULAR INFLAMMATORY DISORDERS AND DISEASES
#11141COMPOSITION COMPRISING FEXOFENADINE
#11142HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY
#11143METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH AMD3100 AND TACROLIMUS
#11144PHARMACEUTICAL AGENTS TARGETING CANCER STEM CELLS
#11145Methods of treating HIV-associated neurological disorders (HAND)
#11146INDOLINE DERIVATIVES FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
#11147Dual antagonist of PGD/DPr2 and Thromboxane A/TPr receptors and use for treatment of maladaptive immune response or thrombotic diathesis
#11148COMPOSITIONS OF FULVIC ACID AND CANNABINOID AND USES THEREOF
#11149NOVEL DEPSIDE DIMERIC COMPOUNDS FOR SKELETAL MUSCLE MODULATION, METHODS AND USES THEREOF
#11150NOVEL FORMULATIONS COMPRISING MELFLUFEN
#11151BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
#11152USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER
#11153Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
#11154Prevention and treatment of diabetic nephropathy
#11155MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION
#11156High-Efficiency Transdermal Patches
#11157SLEEP AID TRANSDERMAL PATCH AND ITS PROCESS OF PREPARATION
#11158Edible Film Comprising Adjacent Conjoined Strips
#11159Pharmaceutical compositions of pimobendan
#11160Synthetic progestogens and pharmaceutical compositions comprising the same
#11161Extended release pharmaceutical formulation
#11162Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement
#11163POWDER FORMULATION FOR INTRANASAL ADMINISTRATION, AND MANUFACTURING METHOD THEREOF
#11164CHEWABLE PHARMACEUTICAL DOSAGE FORMS
#11165Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#11166BIOMARKERS FOR SELINEXOR
#11167METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS
#11168HIPK INHIBITORS AND METHODS OF USE THEREOF
#11169MicroRNA-198 as a tumor suppressor in ovarian cancer
#11170Modified short interfering nucleic acid (siNA) molecules and uses thereof
#11171Genome-edited induced pluripotent stem cells, and cells derived therefrom, and uses thereof
#11172Production of red blood cells and platelets from stem cells
#11173'SMART' HYDROGEL FOR THE RADIOSENSITIZATION AND SUSTAINED DELIVERY OF THERAPEUTICS TRIGGERED BY IRRADIATION
#11174METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS
#11175FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
#11176USE OF THE IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVIATING SYMPTOMS OF PULMONARY SARCOIDOSIS
#11177Bispecific Antibodies for use in treatment of NLRC4-GOF inflammasomapathy
#11178Models and Methods Useful for the Treatment of Serrated Colorectal Cancer
#11179Antibody molecules to dengue virus and uses thereof
#11180T cell receptors
#11181Methods of using interleukin-2 agents
#11182Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
#11183Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
#11184FUSED POLYCYCLIC PYRIDONE COMPOUNDS AS INFLUENZA VIRUS REPLICATION INHIBITORS
#11185Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
#11186Azaaromatic amide derivatives for the treatment of cancer
#11187Imidazoquinoline compounds and prodrugs thereof
#11188GLP-1R modulating compounds
#11189SULFINYLPYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER
#11190COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#11191Fluorochemical targeted therapies
#11192DELIVERY OF MACROMOLECULES INTO THE CENTRAL NERVOUS SYSTEM VIA THE BLOODSTREAM
#11193TREATMENT OF CAR T-CELL TOXICITY
#11194Pharmaceutical compositions comprising meloxicam
#11195TARGETED SYNERGISTIC CANCER IMMUNOTHERAPY
#11196THERAPEUTIC AGENTS FOR PANCREATIC CANCER
#11197Method and system for protecting monarch butterflies from pesticides
#11198Compositions, methods and uses for thermally stable multi-targeted antigens
#11199Method for preventing or treating metabolic disorder
#11200METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS
#11201Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
#11202THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA
#11203METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE
#11204Synthetic neuromodulatory peptides
#11205CO-ADMINISTRATION COMPOSITION FOR PREVENTING OR TREATING HYPERCHOLESTEROLEMIA, CONTAINING BALLOON-FLOWER EXTRACT OR PLATYCODIN D DERIVED THEREFROM AS ACTIVE INGREDIENT
#11206Tetraselmis Extract
#11207METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF
#11208PRIMING WITH TARGETED ACTIVATED T CELLS CAN ENHANCE CHEMO RESPONSIVENESS OF CANCER CELLS
#11209Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
#11210COMBINATION THERAPIES BASED ON PD1 AND IL-17B INHIBITORS
#11211Methods for treating or preventing ophthalmological conditions
#11212Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
#11213OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD
#11214THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLERANCE
#11215Methods for Predicting Neisseria Spp. Susceptibility to Cefixime
#11216EZH2 inhibitors for treating lymphoma
#112176-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes
#11218PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER PATIENTS
#11219PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
#11220USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#11221COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS
#11222Inhibitors of Multidrug Resistance Transporter P-Glycoprotein
#11223N-substituted indole derivatives as PGE2 receptor modulators
#11224CANCER TREATMENT MODALITIES
#11225TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION
#11226FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF UROTHELIAL CARCINOMA
#11227Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto
#11228COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNE CHECKPOINT THERAPY
#11229COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#11230LANABECESTAT FOR WEIGHT LOSS
#11231Opioid receptor ligands and methods of using and making same
#11232Indane-amines as PD-L1 antagonists
#11233COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE
#11234Topical roflumilast formulation having antifungal properties
#11235Tip60 Inhibitors and Methods of Use for Cardiovascular Disease
#11236Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation
#11237METHODS OF TREATING PULMONARY DISEASES AND DISORDERS
#11238JAK1 pathway inhibitors for the treatment of vitiligo
#11239COMBINED PREPARATION COMPRISING AN ANTHOCYANIN COMPOSITION AND AN ANTIVIRAL AGENT
#11240Treatment of circadian rhythm disorders
#11241DEPSIDE TRIMERIC COMPOUNDS FOR SKELETAL MUSCLE MODULATION
#11242PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME
#11243Calcium lactate compositions and methods of use
#11244TREATMENT OF MAJOR DEPRESSIVE DISORDER AND SUICIDAL IDEATIONS THROUGH STIMULATION OF HIPPOCAMPAL NEUROGENESIS UTILIZING PLANT-BASED APPROACHES
#11245DIETARY SUPPLEMENT COMPRISING LUTEIN FOR TELOMERE PROTECTION, AND METHOD FOR PRODUCTION THEREOF
#11246NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING
#11247NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING
#11248POLYMERIC NANOPARTICLES
#11249MULTIFUNCTIONAL POLYMER-NANOPARTICLE COMPOSITE FOR FIRST AID AND WOUND CARE APPLICATIONS
#11250SURGICAL DEVICE
#11251Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity
#11252Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity
#11253COSMETIC COTAINING ULTRAVIOLET WAVELENGTH CONVERTING SUBSTANCE AND MEDICINAL AGENT
#11254COMPOSITION COTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE AND HYDROPHOBIZED SILICA AND/OR HYDROPHOBIZED STARCH
#11255Nutritional composition and infant formula for promoting de novo myelination
#11256Nutritional composition and infant formula for promoting myelination of the brain
#11257PROBIOTICS FOR REDUCING METHANE PRODUCTION
#11258BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF
#11259PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS
#11260RNA ENGINEERED T CELLS FOR THE TREATMENT OF CANCER
#11261A MICRO PHYSIOLOGICAL MODEL FOR NEURONAL AND MUSCULAR DISEASES AND DISORDERS
#11262Antagonistic CD40 monoclonal antibodies and uses thereof
#11263Methods of sensitizing cancer to immunotherapy
#11264Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)
#11265BIO-RESPONSIVE ANTIBODY COMPLEXES FOR ENHANCED IMMUNOTHERAPY
#11266COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES INVOLVING CXCL1 FUNCTION
#11267TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY
#11268CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
#11269Treatment of ischemia
#11270HIGH-AFFINITY CU(I) LIGANDS AND METHODS OF USE THEREOF
#11271Tricyclic compounds
#11272HETEROCYCLIC COMPOUNDS AND USES THEREOF
#11273METHODS AND MATERIALS FOR INCREASING OR MAINTAINING NICOTINAMIDE MONONUCLEOTIDE ADENYLYL TRANSFERASE-2 (NMNAT2) POLYPEPTIDE LEVELS
#11274TAIRE FAMILY KINASE INHIBITORS AND USES THEREOF
#11275THERAPEUTIC AGENTS AND METHODS OF TREATMENT
#11276Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer
#11277AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS
#11278PERIPHERAL NERVE STIMULATION DEVICE FOR AFFECTING PARASYMPATHETIC AND SYMPATHETIC ACTIVITY TO ACHIEVE THERAPEUTIC EFFECTS
#11279INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE
#11280COMBINATION OF ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE AND PARP INHIBITOR
#11281MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#11282Bioorthogonal compositions
#11283COMPOSITIONS AND METHODS FOR MONITORING, DIAGNOSIS, PROGNOSIS, DETECTION, AND TREATMENT OF CANCER
#11284Afucosylated Anti-FGFR2IIIB Antibodies
#11285MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF
#11286Methods of Enhancing Protection Against Organ and Vascular Injury, Hematopoietic Recovery and Survival in Response to Total Body Radiation/Chemical Exposure
#11287USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS
#11288Anti-Bacterial Combination Therapy
#11289Formulations for treating cramps and spasms
#11290TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#11291Modified microorganisms expressing saga and related compositions for immunomodulation against infection and cancer immunotherapy
#11292FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY
#11293Combination Treatment for Hematological Cancers
#11294PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same
#11295COMBINATORIAL DRUG TREATMENT OF CANCER
#11296METHODS AND COMPOSITIONS FOR TREATING EUKARYOTIC INFECTIONS VIA ALTERING AGGREGATION DYNAMICS OF RAPTOR/KOG1
#11297THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES
#11298CANCER THERAPY
#11299NOVEL STAT3 INHIBITORS IDENTIFIED BY STRUCTURE-BASED VIRTUAL SCREENING INCORPORATING SH2 DOMAIN FLEXIBILITY
#11300COMBINED USE OF A-NOR-5alpha ANDROSTANE COMPOUND DRUG AND ANTICANCER DRUG
#11301COMPOUNDS AND THERAPEUTIC USES THEREOF
#11302HETEROCYCLIC COMPOUNDS AND USES THEREOF
#11303METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
#11304TREATMENT OF CNS CONDITIONS
#11305TREATMENT OF RAYNAUD'S DISEASE
#11306Treatment of progressive neurodegenerative disease with ibudilast
#11307METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC
#11308Pharmaceutical combination for the treatment of cancer
#11309COMPOSITIONS FOR PATHOGENESIS-DIRECTED THERAPY AND TREATMENTS OF SKIN DISEASES AND DISORDERS
#11310Treatment of circadian rhythm disorders
#11311Treatment of circadian rhythm disorders
#11312Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity
#11313METHOD FOR TREATING FEMALE NON-SMOKERS WITH NON-SMALL CELL LUNG CANCER
#11314PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT
#11315METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#11316Topical compositions for pain relief, manufacture and use
#11317Bis-Biguanide Compounds, Pharmaceutical Compositions and Uses in Managing Cancer
#11318CORONAVIRUS TREATMENT COMPOSITIONS AND METHODS
#11319PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF
#11320CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATION WITH A BIOACTIVE IMMUNOSTIMULATORY AGENT
#11321BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD
#11322SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH METFORMIN
#11323HIGH-INTENSITY OUTDOOR SPORTS FOOD SUPPLEMENT RICH IN BIOLOGICAL IONS AND PREPARATION METHOD THEREOF
#11324DUAL INHIBITION OF PLEXIN-B1 AND PLEXIN-B2
#11325Compound for treatment of heart failure
#11326Methods, compositions, and kits for producing beige adipocytes and treating metabolic disorders
#11327FLUID SYSTEM FOR PRODUCING EXTRACELLULAR VESICLES COMPRISING A THERAPEUTIC OR IMAGING AGENT AND METHOD THEREOF
#11328Anti-FXI/FXIa antibody and use thereof
#11329METHODS AND COMPOSITIONS FOR ANTI-CD73 ANTIBODIES AND VARIANTS
#11330INTERLEUKIN-4 RECEPTOR ANTIBODY AND APPLICATION THEREOF
#11331Anti-IL36R antibodies
#11332Anti-FGFR2 antibodies and methods of use thereof
#11333ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
#11334Anti-CD112R compositions and methods
#11335ANTIBODY TO TIGIT AND USE THEREOF
#11336Anti-CD48 antibodies, antibody drug conjugates, and uses thereof
#11337HUMANIZED ANTI-FOLATE RECEPTOR 1 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#11338COMBINATION IMMUNOTHERAPY
#11339CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY
#11340HETEROCYCLIC COMPOUNDS AND USES THEREOF
#11341Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applications
#11342ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#11343Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
#113444-hydroxybutyric acid analogs
#11345SYSTEMS AND METHODS FOR PHOTOBIOMODULATION
#11346COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#11347ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS
#11348Drug Adsorbed Highly Porous Activated Carbon for Enhanced Drug Delivery
#11349METHOD OF TREATING INFECTIVE ENDOCARDITIS
#11350METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
#11351METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES
#11352COMPOSITIONS COMPRISING CHOLINE
#11353USE OF ANNEXIN V AS A METHOD TO BLOCK TUMOR INDUCED IMMUNOSUPPRESSION OF THE INNATE IMMUNE RESPONSE
#11354COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
#11355Modulation of tumor immunity by protein-mediated Odelivery
#11356Pharmaceutical compositions
#11357COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)
#11358Inhibitors for proliferating cell nuclear antigen and uses
#11359METHODS AND COMPOSITIONS FOR PROMOTING HEALTH IN A SUBJECT
#11360Methods for treating microbial infections using caudovirales bacteriophages
#11361USE OF BACILLUS AMYLOLIQUEFACIENS AND/OR BACILLUS SUBTILIS FOR THE ENHANCEMENT OF ACTIVE PROBIOTIC COMPOSITIONS OR FOR THE ACTIVATION OF INACTIVE PROBIOTIC COMPOSITIONS, COMPOSITIONS THUS OBTAINED, AND RELATED METHOD
#11362BACILLUS COAGULANS AND BACILLUS SUBTILIS FOR THE PREVENTION AND TREATMENT OF FUNCTIONAL GASTRO-INTESTINAL DISORDERS
#11363Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer
#11364Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer
#11365Carbon monoxide-based therapies and implantable devices for the treatment of vascular disease
#11366Derivatized chitosan polymers and methods of treating vascular disorders
#11367METHODS OF TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH INCREASED TET LEVEL, INCREASED H19 LEVEL, INCREASED LEVEL OF TGF SIGNALING, OR ANY COMBINATION THEREOF
#11368MIR-181 INHIBITORS AND USES THEREOF
#11369Method and compositions for treating Coronavirus infection
#11370METHODS FOR TREATING SUBJECTS WITH CHRONIC KIDNEY DISEASE
#11371NITRIC OXIDE-RELEASING ANTIBACTERIAL COMPOUNDS, FORMULATIONS, AND METHODS PERTAINING THERETO
#11372TREATMENT OF FIBROIDS WITH VITAMIN D AND AN AGENT SUCH AS EPIGALLOCATECHIN GALLATE (EGCG)
#11373Method for the treatment of Dravet Syndrome
#11374METHODS OF TREATING CANCER
#11375COMPOSITIONS AND METHODS OF TREATING CANCER
#11376SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)
#11377COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE
#11378Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
#11379PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A PD-1 INHIBITOR
#11380TUMOR-SELECTIVE COMBINATION THERAPY
#11381Methods for Treatment of Fabry Disease
#11382Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
#11383COMPOSITIONS AND METHODS FOR CANCER THERAPY
#11384Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus
#11385PARENTERAL NUTRITION FORMULATION
#11386COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
#11387Deuterated forms of acetaminophen and uses thereof
#11388TESOFENSINE FOR REDUCTION OF BODY WEIGHT IN PRADER-WILLI PATIENTS
#11389USE OF VITAMIN K IN COMBINATION WITH ANTICOAGULANTS
#11390PHARMACEUTICAL COMPOSITION
#11391Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#11392CAPSULE WITH INTERNAL DIAPHRAGM FOR IMPROVED BIOAVAILABILITY
#11393ALCOHOL-RESISTANT DRUG FORMULATIONS
#11394FORMULATIONS FOR TREATING PSORIASIS
#11395Pharmaceutical formulation
#11396USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF MEDICAMENT FOR TREATING SOLID TUMORS
#11397METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#11398SMALL MOLECULES FOR INCREASING PRECISE GENOME EDITING EFFICIENCY
#11399BISPECIFIC ANTIBODIES FOR USE IN STEM CELL TRANSPLANTATION
#11400Antagonistic CD40 monoclonal antibodies and uses thereof